R079
R079 (compound 17) is a selective, orally active Nrf2 activator. R079 increases Nrf2 translocation activity (EC50 = 32.41 μM). R079 can neutralize excess levels of reactive oxygen species through activating Nrf2. R079 has anti-inflammatory properties and can be used in multiple sclerosis research .
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2115659-62-4
- Formel: C11H11N3O3S
- Molecular Weight:265.29
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| THP-1 | IC50 |
3.49 μM
Compound: 17
|
Inhibition of LPS-induced IL-23 production in IFN-gamma primed human THP-1 cells preincubated for 1 hr followed by LPS stimulation for 18 hrs by sandwich ELISA
Inhibition of LPS-induced IL-23 production in IFN-gamma primed human THP-1 cells preincubated for 1 hr followed by LPS stimulation for 18 hrs by sandwich ELISA
|
[PMID: 38116420] |
In Vitro
R079 (2-10 μM) increases expression of Nrf2 and HO-1 in THP-1 cells[1].
R079 shows microsomal stability, with t1/2s of >60 min in mouse, rat, dog, monkey and human microsomes [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
PK Parameters for R079 in Balb/c Mice[1]
| Parameter | Balb/c Mice (p.o., 5mg/kg) |
| clearance (mL/min/kg) | 2.01 |
| half-life (h) | 1.0 |
| Vss (L/kg) | 0.14 |
| oral AUC (ng·h/mL) | 22900 |
| oral Cmax (ng/mL) | 19600 (73.96 μM) |
| bioavailability (%F) | 56 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:mouse experimental autoimmune encephalomyelitis (EAE) model[1]
-
Dosage:30, 60, and 90 mg/kg
-
Administration:Oral gavage (p.o.), b.i.d for 28 days
-
Result:Demonstrated a robust dose-dependent reduction in disease severity (41% reduction in clinical score at 30 mg/kg to 89% at 60 mg/kg), p.o. (60, 90 mg/kg) increased levels of Nrf2 for an 8 h period in mouse thymus.
Chemical Information
-
CAS. Nr. 2115659-62-4
-
Molecular Weight 265.29
-
Formel C11H11N3O3S
-
SMILES
O=S(/C=C/N1C(N(C=N1)C)=O)(C2=CC=CC=C2)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)